Who is sponsoring NCT01765985?

NCT01765985 is sponsored by Pr PASSERON.

What condition does NCT01765985 study?

NCT01765985 studies Psoriasis Palm & Soles.

What drugs are being tested in NCT01765985?

Interventions: PSORIAMED, PLACEBO.

What is the status of NCT01765985?

NCT01765985 is currently COMPLETED.

Last reviewed 2015-01-13 · How we verify

Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current

NCT01765985 Phase 2/Phase 3 COMPLETED

Interferential current has shown promising results for treating psoriasis with a good tolerance. Prospective randomized studies versus placebo are required to confirm the interest of such an approach. The Main objective is to assess the efficacy of interferential current for treating palmoplantar psoriasis. Secondary objectives is to assess the subjective efficacy by the patients, the efficacy on the nails, to study the potential side effects.

Details

Lead sponsor	Pr PASSERON
Phase	Phase 2/Phase 3
Status	COMPLETED
Enrolment	36
Start date	2011-09
Completion	2013-09

Conditions

Psoriasis Palm & Soles

Interventions

PSORIAMED
PLACEBO

Primary outcomes

Test IGA — 12 weeks
IGA (investigator Global assessment) score from 0 (healed) to 4 (worst) at 12 and 24 weeks. The criteria of success will be IGA 0 or 1 at W12.

Countries

France